VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 100 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,607,345 | -40.9% | 603,552 | -9.8% | 0.01% | -36.4% |
| Q2 2023 | $4,409,264 | +27.8% | 669,084 | +31.6% | 0.01% | +10.0% |
| Q1 2023 | $3,451,058 | +4.6% | 508,256 | +13.9% | 0.01% | 0.0% |
| Q4 2022 | $3,298,682 | -6.3% | 446,371 | +25.2% | 0.01% | -16.7% |
| Q3 2022 | $3,522,000 | -21.1% | 356,524 | -12.9% | 0.01% | -20.0% |
| Q2 2022 | $4,462,000 | +30.2% | 409,368 | +35.0% | 0.02% | +50.0% |
| Q1 2022 | $3,428,000 | -34.0% | 303,133 | -8.5% | 0.01% | -9.1% |
| Q4 2021 | $5,197,000 | +148.1% | 331,259 | +171.0% | 0.01% | +120.0% |
| Q3 2021 | $2,095,000 | -60.1% | 122,245 | -49.9% | 0.01% | -58.3% |
| Q2 2021 | $5,245,000 | +93.4% | 243,841 | +35.0% | 0.01% | +71.4% |
| Q1 2021 | $2,712,000 | +327.8% | 180,587 | +274.2% | 0.01% | +250.0% |
| Q4 2020 | $634,000 | -47.2% | 48,257 | -54.0% | 0.00% | -66.7% |
| Q2 2020 | $1,201,000 | -30.7% | 105,003 | -37.3% | 0.01% | -57.1% |
| Q1 2020 | $1,734,000 | -73.1% | 167,411 | -57.4% | 0.01% | -26.3% |
| Q4 2019 | $6,445,000 | +110.5% | 392,718 | +70.3% | 0.02% | +90.0% |
| Q3 2019 | $3,062,000 | -50.8% | 230,539 | -47.8% | 0.01% | -52.4% |
| Q2 2019 | $6,228,000 | -16.0% | 442,002 | +9.7% | 0.02% | -12.5% |
| Q1 2019 | $7,415,000 | -12.5% | 402,964 | +24.3% | 0.02% | -27.3% |
| Q4 2018 | $8,474,000 | +2.5% | 324,309 | -10.0% | 0.03% | +43.5% |
| Q3 2018 | $8,270,000 | +22.4% | 360,359 | +1.6% | 0.02% | +15.0% |
| Q2 2018 | $6,758,000 | +129.9% | 354,751 | +103.4% | 0.02% | +100.0% |
| Q1 2018 | $2,939,000 | +949.6% | 174,437 | +848.0% | 0.01% | +900.0% |
| Q4 2017 | $280,000 | -92.3% | 18,400 | -91.0% | 0.00% | -92.3% |
| Q3 2017 | $3,651,000 | +17.5% | 203,958 | +7.0% | 0.01% | +18.2% |
| Q2 2017 | $3,106,000 | +558.1% | 190,582 | +464.9% | 0.01% | +450.0% |
| Q1 2017 | $472,000 | -84.9% | 33,735 | -82.8% | 0.00% | -83.3% |
| Q4 2016 | $3,127,000 | +6.9% | 196,066 | +11.5% | 0.01% | +9.1% |
| Q3 2016 | $2,925,000 | +164.9% | 175,779 | +78.2% | 0.01% | +120.0% |
| Q2 2016 | $1,104,000 | -25.9% | 98,615 | -46.5% | 0.01% | -50.0% |
| Q2 2013 | $1,489,000 | – | 184,290 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,715,000 | $19,345,000 | 7.65% |
| Avoro Capital Advisors LLC | 2,124,593 | $23,965,000 | 6.23% |
| Asymmetry Capital Management, L.P. | 118,707 | $1,339,000 | 2.98% |
| ARMISTICE CAPITAL, LLC | 760,000 | $8,573,000 | 2.93% |
| Consonance Capital Management LP | 1,436,796 | $16,207,000 | 2.28% |
| Palo Alto Investors LP | 3,997,108 | $45,087,000 | 2.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,784,157 | $53,965,000 | 2.09% |
| PURA VIDA INVESTMENTS, LLC | 247,500 | $2,792,000 | 1.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,943,267 | $21,920,000 | 1.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 513,390 | $5,791,000 | 0.74% |